Literature DB >> 21448680

Glucose metabolism disorders and the risk of cancer.

Paweł Piątkiewicz1, Anna Czech.   

Abstract

Diabetes and cancer are diseases which take the size of an epidemic spread across the globe. Those diseases are influenced by many factors, both genetic and environmental. Precise knowledge of the complex relationships and interactions between these two conditions is of great importance for their prevention and treatment. Many epidemiological studies have shown that certain types of cancer, especially gastrointestinal cancers (pancreas, liver, colon) and also the urinary and reproductive system cancers in women are more common in patients with diabetes or related metabolic disorders. There are also studies showing the inverse relationship between diabetes and cancer, or the lack of it, but they are less numerous and relate mainly to prostate cancer or squamous cell carcinoma of the esophagus. Epidemiological studies, however, do not say anything about the mechanisms of these dependencies. For this purpose, molecular research is needed on the metabolism of cells (including tumor cells) and on metabolic dysfunctions that arise due to changes in the cell environment taking place in the sick, as well as in the intensely treated human organism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448680     DOI: 10.1007/s00005-011-0119-0

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  9 in total

1.  Impaired glucose metabolism treatment and carcinogenesis.

Authors:  Artur Matyszewski; Anna Czarnecka; Maciej Kawecki; Piotr Korzeń; Ilan J Safir; Wojciech Kukwa; Cezary Szczylik
Journal:  Oncol Lett       Date:  2015-06-04       Impact factor: 2.967

2.  Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.

Authors:  Jianjun Han; Lu Zhang; Hui Guo; Weiya Z Wysham; Dario R Roque; Adam K Willson; Xiugui Sheng; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2015-06-30       Impact factor: 5.482

3.  KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.

Authors:  Kening Zhou; Jing Lin; Mimi Dai; Yingying He; Jingui Xu; Qian Lin
Journal:  J Bioenerg Biomembr       Date:  2021-11-03       Impact factor: 2.945

4.  Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis.

Authors:  Simona Di Francesco; Raffaele L Tenaglia
Journal:  Cent European J Urol       Date:  2014-01-27

5.  Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.

Authors:  Carla Micucci; Silvia Orciari; Alfonso Catalano
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer.

Authors:  Paweł Piątkiewicz; Małgorzata Bernat-Karpińska; Tomasz Miłek; Michał Rabijewski; Elżbieta Rosiak
Journal:  Diabetol Metab Syndr       Date:  2016-06-13       Impact factor: 3.320

7.  Preoperative fasting hyperglycemia is an independent prognostic factor for postoperative survival after gallbladder carcinoma radical surgery.

Authors:  Peng Zheng; Xiaoqian Wang; Zhong Hong; Feixia Shen; Qiyu Zhang
Journal:  Cancer Manag Res       Date:  2019-02-12       Impact factor: 3.989

Review 8.  Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.

Authors:  Ya Wang; Xinling Zeng; Jie Tan; Yi Xu; Cunjian Yi
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

Review 9.  Current perspectives between metabolic syndrome and cancer.

Authors:  Carla Micucci; Debora Valli; Giulia Matacchione; Alfonso Catalano
Journal:  Oncotarget       Date:  2016-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.